Fennec Pharmaceuticals, Inc. (FENC)
9.81
-0.12
(-1.21%)
USD |
NASDAQ |
May 26, 13:09
Fennec Pharmaceuticals Total Assets (Quarterly) : 71.82M for March 31, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| CytomX Therapeutics, Inc. | 359.36M |
| Gossamer Bio, Inc. | 128.90M |
| REGENXBIO, Inc. | 341.89M |
| Zymeworks, Inc. | 478.22M |
| Apellis Pharmaceuticals, Inc. | 1.083B |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 34.15M |
| Shareholders Equity (Quarterly) | 37.68M |
| Current Ratio | 6.977 |
| Net Debt Paydown Yield | 1.70% |